Literature DB >> 3404259

Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.

S Ono1, M Fukunaga, N Otsuka, K Nagai, K Morita, T Furukawa, A Muranaka, S Yanagimoto, T Tomomitsu, A Tabuchi.   

Abstract

In a patient with ocular melanoma, scintigraphy with N-isopropyl-p-[123I]-iodoamphetamine [( 123I]IMP) clearly delineated the histologically proven ocular lesion. In a tissue distribution study, using the resected specimen, a significantly high accumulation of the radioactivity was confirmed in tumor tissue. Thus, [123I]IMP scintigraphy provided specific localization of an ocular melanoma.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3404259

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  3 in total

1.  Diagnosis of atypical choroidal malignant melanoma using N-isopropyl-p-[123I]-iodoamphetamine single photon emission computed tomography.

Authors:  Toshinobu Kubota; Katsuhiko Kato; Shu Ichihara; Hiroshi Hirose
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.447

2.  Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.

Authors:  D F Schaling; J A Oosterhuis; M J Jager; H Kakebeeke-Kemme; E K Pauwels
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors.

Authors:  Sudha Garg; Kanchan Kothari; Shankar R Thopate; Aniruddha K Doke; Pradeep K Garg
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.